Current disease status-First occurrence of the cancer - Page 28 of 59 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Alternative hormone therapy with enzalutamide – effective regardless of metastasis site

Alternative hormone therapy with enzalutamide – effective regardless of metastasis site

Posted by on Apr 16, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the effects of enzalutamide (Xtandi) with respect to the site of metastatic castration-resistant prostate cancer. Researchers concluded that enzalutamide is a safe and effective treatment for all sites of metastases studied. Some background When prostate cancer spreads outside of the prostate (also called...

Read More

Searching for men with PSA levels rising after primary treatment to test an immunotherapy vaccine

Posted by on Apr 11, 2016 in Prostate cancer | 0 comments

In a nutshell This phase II trial aims to evaluate the effectiveness of a personalized peptide-based vaccine (Multi-Epitope TARP) on preventing progression of localized prostate cancer. The main outcome to be investigated is disease progression based on blood tests. The trial is recruiting in Maryland (USA). The details Immunotherapy has recently...

Read More

Is prostate surgery beneficial for older men with additional medical conditions?

Is prostate surgery beneficial for older men with additional medical conditions?

Posted by on Apr 2, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefits of prostate surgery among older men with high-risk prostate cancer and additional medical conditions. Researchers concluded that prostate surgery is a suitable treatment option for older high-risk prostate cancer patients with few additional medical conditions. Some background Surgical removal of the...

Read More

Is abiraterone acetate also suitable for older men with castration resistant prostate cancer?

Is abiraterone acetate also suitable for older men with castration resistant prostate cancer?

Posted by on Mar 25, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined abiraterone acetate (Zytiga) as a treatment option for older men with metastatic castration-resistant prostate cancer. Researchers concluded that abiraterone acetate improves overall survival in younger as well as older men with metastatic castration resistant prostate cancer. Some background...

Read More

The influence of infection on breast cancer recurrence following breast reconstruction

The influence of infection on breast cancer recurrence following breast reconstruction

Posted by on Mar 21, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the influence of possible infections following breast reconstruction on the risks of breast cancer recurrence. This study showed that post-operative complications or infections had a significant impact on the rates of breast cancer recurrence. Some background Breast reconstruction surgery is a procedure...

Read More